FYZOCLAD Trademark

Trademark Overview

On Thursday, April 7, 2016, a trademark application was filed for FYZOCLAD with the United States Patent and Trademark Office. The USPTO has given the FYZOCLAD trademark a serial number of 86967944. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 25, 2019. This trademark is owned by Pfizer Inc.. The FYZOCLAD trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparation for the treatment of autoimmune diseases; anti-inflammatory pharmaceutical preparations
fyzoclad

General Information

Serial Number86967944
Word MarkFYZOCLAD
Filing DateThursday, April 7, 2016
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 25, 2019
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 30, 2016

Trademark Statements

Goods and Servicespharmaceutical preparation for the treatment of autoimmune diseases; anti-inflammatory pharmaceutical preparations

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, April 12, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NamePfizer Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10017
Party NamePfizer Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Monday, November 25, 2019ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, November 25, 2019ABANDONMENT - NO USE STATEMENT FILED
Friday, April 12, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 11, 2019EXTENSION 5 GRANTED
Monday, April 8, 2019EXTENSION 5 FILED
Thursday, April 11, 2019CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, April 8, 2019TEAS EXTENSION RECEIVED
Friday, September 28, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 26, 2018EXTENSION 4 GRANTED
Wednesday, September 26, 2018EXTENSION 4 FILED
Wednesday, September 26, 2018TEAS EXTENSION RECEIVED
Tuesday, April 17, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, April 13, 2018EXTENSION 3 GRANTED
Friday, April 13, 2018EXTENSION 3 FILED
Friday, April 13, 2018TEAS EXTENSION RECEIVED
Tuesday, October 17, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, October 13, 2017EXTENSION 2 GRANTED
Friday, October 13, 2017EXTENSION 2 FILED
Friday, October 13, 2017TEAS EXTENSION RECEIVED
Tuesday, March 14, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 10, 2017EXTENSION 1 GRANTED
Friday, March 10, 2017EXTENSION 1 FILED
Friday, March 10, 2017TEAS EXTENSION RECEIVED
Tuesday, October 25, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 30, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 30, 2016PUBLISHED FOR OPPOSITION
Wednesday, August 10, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, July 25, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, July 21, 2016ASSIGNED TO EXAMINER
Tuesday, April 12, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, April 11, 2016NEW APPLICATION ENTERED IN TRAM

Related Keywords

fyzoclad pharmaceutical inflammatory preparations anti autoimmune preparation treatment diseases